ArticleCancer2017
Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States.
Article in Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Trial
- The relationship of race/ethnicity and age with medical financial hardship for cancer survivors in the United States.Journal of cancer survivorship : research and practice · 2026Article
- Financial difficulty among patients with cancer participating in clinical trials and its association with patient survival and quality of life.Journal of the National Cancer Institute · 2025Article
- Non-monetary burdens of out-of-pocket costs incurred by patients and caregivers for medical care: a scoping review.BMJ open · 2025Article
- Financial Toxicity and Kidney Disease in Children and Adults: A Scoping Review.International journal of nephrology and renovascular disease · 2025Review
- Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview Survey.JCO oncology practice · 2024Article
- Pilot implementation and qualitative evaluation of a financial hardship screening among Native American patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Financial hardship screening among Native American patients with cancer: a qualitative analysis.BMC health services research · 2024Article
- Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Mixed Methods Approach to Identify Effective Interventions.Urology practice · 2024Article
- Beyond Medical Bills: High Prevalence of Financial Toxicity and Diverse Management Strategies Among Vietnamese Patients With Cancer.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2024Article
- Evaluation of Financial Interventions in Breast Cancer Care Worldwide: A Systematic Review.Plastic and reconstructive surgery. Global open · 2024Article
- Medical financial hardship between young adult cancer survivors and matched individuals without cancer in the United States.JNCI cancer spectrum · 2024Article
- The cost burden of metastatic prostate cancer in the US populations covered by employer-sponsored health insurance.Cancer · 2023Article
- Association of Employment Disruptions and Financial Hardship Among Individuals Diagnosed with Cancer in the United States: Findings from a Nationally Representative Study.Cancer research communications · 2023Article
- Healthcare affordability and effects on mortality among adults with liver disease from 2004 to 2018 in the United States.Journal of hepatology · 2023Article
- Career disruption and limitation of financial earnings due to cancer.JNCI cancer spectrum · 2023Article
- Financial toxicity assessment and associated factors analysis of patients with cancer in China.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Article
- Perceived Appropriateness of Assessing for Health-related Socioeconomic Risks Among Adult Patients with Cancer.Cancer research communications · 2023Article
- Impact of facilitating continued accessibility to cancer care during COVID-19 lockdown on perceived wellbeing of cancer patients at a rural cancer center in Rwanda.PLOS global public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThere is limited evidence from nationally representative samples about changes in prescription drug use for financial reasons among cancer survivors in the United States.
methodsThe 2011 to 2014 National Health Interview Survey was used to identify adults who reported ever having been told they had cancer (cancer survivors; n = 8931) and individuals without a cancer history (n = 126,287). Measures of changes in prescription drug use for financial reasons included: 1) skipping medication doses, 2) taking less medicine, 3) delaying filling a prescription, 4) asking a doctor for lower cost medication, 5) buying prescription drugs from another country, and 6) using alternative therapies. Multivariable logistic regression analyses were controlled for demographic characteristics, number of comorbid conditions, interactions between cancer history and number of comorbid conditions, and health insurance coverage. Main analyses were stratified by age (nonelderly, ages 18-64 years; elderly, ages ≥65 years) and time since diagnosis (recently diagnosed, <2 years; previously diagnosed, ≥2 years).
resultsAmong nonelderly individuals, both recently diagnosed (31.6%) and previously diagnosed (27.9%) cancer survivors were more likely to report any change in prescription drug use for financial reasons than those without a cancer history (21.4%), with the excess percentage changes for individual measures ranging from 3.5% to 9.9% among previously diagnosed survivors and from 2.6% to 2.7% among recently diagnosed survivors (P < .01). Elderly cancer survivors and those without a cancer history had comparable rates of changes in prescription drug use for financial reasons.
conclusionsNonelderly cancer survivors are particularly vulnerable to changes in prescription drug use for financial reasons, suggesting that targeted efforts are needed. Cancer 2017;123:1453-1463. © 2016 American Cancer Society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.